Synlogic (SYBX) Tops Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results
November 12, 2019 4:02 PM ESTSYNB1618 solid oral bridging study ongoing and SYNB1891 immuno-oncology study open
Company ends 3Q2019 with approximately $139 million in cash, cash equivalents and investments supporting projected runway through 2021
Management to host conference call and webcast at 5:00 pm ET today
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Synlogic, Inc. (Nasdaq: SYBX), a clinical... More



